Elicio Therapeutics, Inc. — Director's Dealing 2021

Mar 19, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Angion Biomedica Corp. (ANGN)
CIK: 0001601485
Period of Report: 2021-03-17

Reporting Person: Neylan John F. (See Remarks)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-03-17	Common Stock	S	442	$19.13	Disposed	38453	Direct

Footnotes

F1: The shares were sold to the Issuer solely to satisfy tax or other government withholding obligations in connection with the vesting of shares subject to a Restricted Stock Awards ("RSAs") of the Issuer.